Divis Laboratories Share Price

₹ 11,565.50

+₹468.50 (4.22%)
1D
Last updated 09 Nov, 2026, 15:57 IST
NSE: DIVISLAB
|
Pharmaceuticals

Divis Laboratories Share Price Today

As of 10 Nov 2026, Divis Laboratories share price is ₹11,565.50. The stock opened at ₹11,097.00, compared to its previous close of ₹11,097.00. During today's trading session, Divis Laboratories share price moved in the range of ₹11,071.00 to ₹11,824.00, with an average price of ₹11,447.50 for the day. Looking at its last 52-week, the stock has touched a low of ₹5,647.50 and a high of ₹11,824.00. On the performance front, Divis Laboratories share price has increased by 72.35% over the last six months and is up 73.75% on a year-on-year basis.

Share price over the last 1 day rose from 11184.50 to 11565.50, ranging between 11184.50 and 11811.00.
₹11,071.00
4.22% up today
₹11,824.00
1D LOW
1D HIGH

Divis Laboratories Stock Insights

Latest Earning
Op Profit TrendUp by 27.54% QoQ
Latest Earning
Net Profit TrendUp by 24.94% QoQ
Latest Earning
Revenue TrendUp by 19.91% QoQ
Stock Performance
OutperformingBeat Nifty by 7.86 % in last 1 month
Shareholding Pattern
PromoterPromoter decreased stake by 0.01%
Shareholding Pattern
DIIDII decreased stake by 18.25%
Shareholding Pattern
FIIFII increased stake by 0.89%
Technical Indicators
Volume SpikeVolume is 98.0% above 20-day average on 1 Day interval.
Technical Indicators
Price breakoutPrice has broken above resistance on 1 Day interval.
Divis Laboratories stock performance
Open₹11,097.00
High₹11,824.00
Low₹11,071.00
Prev. close₹11,097.00
Divis Laboratories trading activity
Volume25,86,198
Average traded price₹11,570.43
Last traded time03:57:37 09 Nov
Last traded quantity1
Circuit
L
H
₹10,409.00
₹12,722.00
52-week
L
H
₹5,647.50
₹11,824.00
Mkt Cap Cr
3,07,147.15
P/E
91.33
P/B
17.07
ROA
13.32%
ROE
15.32%
ROCE
19.56%
Quick Ratio
3.5
EV/EBITDA
67.29

Based on fundamentals, this stock's

Performance: 5 out of 5, Excellent
Performance
Excellent
Divi's Lab. outperforming all market indices
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Divi's Lab. appears overvalued compared to its peers
Earnings: 5 out of 5, Excellent
Earnings
Excellent
Divi's Lab. revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,57,073.3141.65.129.61%13.79%18.65%2.3124.07
Torrent Pharmaceuticals1,81,473.5086.539.894.7%11.42%11.37%0.7534.68
Laurus Labs1,28,054.0096.1121.1311.58%22.11%20.91%0.6853.3
Zydus Lifesciences1,19,700.4628.134.357.63%15.1%14.86%0.9116.02
Dr. Reddy's Laboratories1,15,685.1141.922.984.79%7.21%8.58%1.3519.31
Cipla1,13,589.0639.813.216.6%8.18%10.8%2.521.44
Mankind Pharma1,09,911.3048.566.257.82%12.76%14.68%0.7425.88
Aurobindo Pharma1,03,913.2526.72.76.46%10.13%12.76%1.1512.52
Lupin91,229.9517.623.8313.08%21.65%24.54%1.4210.23
Glenmark Pharma75,633.3952.126.756.78%18.07%19.86%1.2326.57

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Divis Laboratories Company Background

ISIN
INE361B01024
Sector Market Cap
₹ 307,147.15 Cr

Divi’s Laboratories Ltd is a Hyderabad-based pharmaceutical company. It is a leading manufacturer of active pharmaceutical ingredients (APIs) and supplies its products to more than 100 countries. The company which is counted among the top API manufacturers in the world has been operating for the last 30 years.

Divi’s started as Divi’s Research Centre (DRC) in 1990. It set up its first manufacturing unit in Hyderabad in 1995 and received the USFDA inspection for the first time in 2000. The company set up its second manufacturing unit near Vishakhapatnam in 2002 and a year later was listed on BSE and NSE.

The company entered into the nutraceuticals segment in 2007. It also set up a new research unit in Hyderabad in 2010.

At present, Divi’s Laboratories has 16,500 trained professionals across departments and around 400 scientists working at its three research centres. It has two manufacturing facilities at Vizag and Hyderabad.

Business highlights

Divi’s Lab has a market valuation of Rs 98,600 crore as of December 19, 2023. Divi’s Lab shares price has dropped nearly 3% in three years.

The company’s business operations span across research and development activities and manufacturing operations. Its two main manufacturing facilities in Vizag and Hyderabad produce thousands of tonnes of APIs that are exported to around 100 countries.

Divi’s Laboratories have three main business segments:

Generic APIs

Divi’s Laboratories offers 30 generic active pharmaceutical ingredients to customers across the world. Its operations are bolstered by backward integration to basic starting materials, devoted production blocks with large batch sizes and significant capacity creation.

The company is a global leader in large-volume generic APIs. It looks to achieve global leadership in molecules and around 10 APIs are in the research and development stage. Its manufacturing plants have been audited by various regulatory authorities, as well as global environmental, health and safety teams.

Customs Synthesis

Divi’s Laboratories is involved in contract manufacturing services (custom synthesis) of APIs and intermediates for global companies. It has a portfolio of products across diverse therapeutic areas. The company has 12 out of the top 20 big pharma companies across US, Europe and Japan as its customers for more than 10 years.

Divi’s being a core generic API manufacturer has a research and development (R&D) team of more than 400 scientists.

Nutraceutical

The nutraceutical plant of Divi’s Laboratories is an integrated facility for the production of API and finished forms of Carotenoids. The company supplies carotenoids to major food, dietary supplement and feed manufacturers around the world.

Divis Laboratories Financial Highlights

  • Revenue: Divis Laboratories reported revenue of ₹11,067.00 crore in FY26 vs ₹9,712.00 crore in FY25. It showed an increase of 13.95% on a yearly basis.
  • Operating Profit: Divis Laboratories reported an operating profit of ₹3,388.00 crore in FY26 vs ₹2,916.00 crore in FY25. It showed an increase of 16.19% on a year-on-year basis.
  • Net Profit: Divis Laboratories reported a net profit of ₹2,568.00 crore in FY26 vs ₹2,191.00 crore in FY25. It showed an increase of 17.21% on a yearly basis.

Divis Laboratories Quarterly Result Highlights

  • Divis Laboratories reported revenue of ₹3,770.00 crore in Sep 2026, compared with ₹3,144.00 crore in Jun 2026, representing an increase of 19.91% on a quarter-on-quarter (QoQ) basis.
  • Divis Laboratories reported an operating profit of ₹1,505.00 crore in Sep 2026, compared with ₹1,180.00 crore in Jun 2026, representing an increase of 27.54% on a quarter-on-quarter (QoQ) basis.
  • Divis Laboratories reported a profit of ₹1,127.00 crore in Sep 2026, compared with ₹902.00 crore in Jun 2026, reflecting an increase of 24.94% on a QoQ basis.
  • The earnings per share (EPS) of Divis Laboratories stood at ₹96.75 during Sep 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
51.88%
FII
20.38%
Other DII
4.50%
Retail and other
8.58%
Mutual funds
14.66%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 202520.08%
Mar 202620.29%
Jun 202620.20%
Sep 202620.38%

Divis Laboratories Investment Returns

1 day
+4.22%
1 week
+14.92%
1 month
+23.83%
1 year
+73.75%
3 years
+230.58%
5 years
+133.59%

Divis Laboratories Share Price History

Divis Laboratories share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
09 Nov 26
₹11,097.00 / ₹11,565.50
+4.22%
08 Nov 26
₹10,850.00 / ₹11,097.00
+7.52%
06 Nov 26
₹10,130.00 / ₹10,320.50
+1.78%
05 Nov 26
₹10,100.00 / ₹10,140.50
+1.03%
Show more

Divis Laboratories Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹10,560.00₹9,360.00₹7,845.00₹7,767.51
Other Income₹507.00₹352.00₹339.00₹344.66
Total Revenue₹11,067.00₹9,712.00₹8,184.00₹8,112.17
Total Expenses₹7,605.00₹6,796.00₹6,021.00₹5,743.54
Profit Before Tax₹3,388.00₹2,916.00₹2,163.00₹2,368.63
Tax₹820.00₹725.00₹563.00₹545.25
Profit After Tax₹2,568.00₹2,191.00₹1,600.00₹1,823.38
EPS - Basic₹96.75₹82.53₹60.27₹68.69
EPS - Diluted₹96.75₹82.53₹60.27₹68.69

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹3,388.00₹2,916.00₹2,163.00₹2,368.63
Income before WC changes₹3,501.00₹3,031.00₹2,244.00₹2,513.57
Change in Assets-₹1,207.00-₹699.00-₹677.00₹505.56
Change in Liabilities₹1,306.00₹145.00₹70.00-₹86.75
Change in WC₹99.00-₹554.00-₹607.00₹418.81
Cash flow from Operations₹2,738.00₹1,653.00₹1,261.00₹2,459.73
Cash flow from Investing-₹2,219.00-₹804.00-₹269.00-₹2,707.62
Cash flow from Financing-₹804.00-₹799.00-₹799.00-₹797.17
Total Cash Flow-₹285.00₹50.00₹193.00-₹1,045.06
Cash (Start of the year)₹413.00₹363.00₹170.00₹1,214.76
Cash (End of the year)₹128.00₹413.00₹363.00₹169.70

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹8,937.00₹6,851.00₹5,795.00₹5,127.03
Current Assets₹11,096.00₹10,081.00₹9,675.00₹9,311.74
Total Assets₹20,033.00₹16,932.00₹15,470.00₹14,438.77
Current Liabilities₹2,043.00₹1,452.00₹1,278.00₹1,101.08
Net Current Asset₹9,053.00₹8,629.00₹8,397.00₹8,210.66
Non-Current Liabilities₹1,229.00₹511.00₹621.00₹570.60
Equity Capital₹16,761.00₹14,969.00₹13,571.00₹12,767.09
Total Equity & Liabilities₹20,033.00₹16,932.00₹15,470.00₹14,438.77

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹10,388.00₹9,198.00₹7,665.00₹7,625.00
Other Income₹506.00₹352.00₹337.00₹349.00
Total Revenue₹10,894.00₹9,550.00₹8,002.00₹7,974.00
Total Expenses₹7,384.00₹6,621.00₹5,870.00₹5,620.00
Profit Before Tax₹3,436.00₹2,929.00₹2,132.00₹2,354.00
Tax₹829.00₹720.00₹556.00₹546.00
Profit After Tax₹2,607.00₹2,209.00₹1,576.00₹1,808.00
EPS - Basic₹98.19₹83.20₹59.37₹68.11
EPS - Diluted₹98.19₹83.20₹59.37₹68.11

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹3,436.00₹2,929.00₹2,132.00₹2,354.10
Income before WC changes₹3,527.00₹3,042.00₹2,204.00₹2,472.24
Change in Assets-₹1,270.00-₹704.00-₹637.00₹528.23
Change in Liabilities₹1,316.00₹130.00₹72.00-₹80.93
Change in WC₹46.00-₹574.00-₹565.00₹447.30
Cash flow from Operations₹2,711.00₹1,650.00₹1,266.00₹2,447.95
Cash flow from Investing-₹2,218.00-₹803.00-₹268.00-₹2,706.75
Cash flow from Financing-₹802.00-₹797.00-₹798.00-₹796.59
Total Cash Flow-₹309.00₹50.00₹200.00-₹1,055.39
Cash (Start of the year)₹394.00₹344.00₹144.00₹1,199.56
Cash (End of the year)₹85.00₹394.00₹344.00₹144.17

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹8,920.00₹6,845.00₹5,790.00₹5,116.00
Current Assets₹11,034.00₹9,979.00₹9,572.00₹9,236.00
Total Assets₹19,954.00₹16,824.00₹15,362.00₹14,352.00
Current Liabilities₹2,019.00₹1,420.00₹1,259.00₹1,079.00
Net Current Asset₹9,015.00₹8,559.00₹8,313.00₹8,157.00
Non-Current Liabilities₹1,224.00₹509.00₹619.00₹568.00
Equity Capital₹16,711.00₹14,895.00₹13,484.00₹12,705.00
Total Equity & Liabilities₹19,954.00₹16,824.00₹15,362.00₹14,352.00
* All values are in INR Crore
Divis Laboratories market depth
Bid quantityBid priceAsk priceAsk quantity
0011565.540
0000
0000
0000
0000
Total bid quantity0
Total ask quantity40
Divis Laboratories technical summary
Bearish indicators5
Neutral indicators1
Bullish indicators2
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
85.23
Bullish
ATR (14)
333.68
Neutral
STOCH(9,6)
88.71
Bearish
STOCH RSI (14)
100
Bearish
ADX(9)
48.13
Bearish
UO(9)
79.64
Bearish
ROC(12)
29.22
Bullish
WillR(14)
-8.54
Bearish
Period
Simple value
Exponential vaue
5D
10632.2
10804.62
10D
10217.3
10362.9
20D
9680
9956.6
50D
9496.48
9421.48
100D
8561.08
8754.74
Volume trend — traded volume by day
9 Nov25L
8 Nov6L
6 Nov8L
5 Nov8L
4 Nov5L
3 Nov6L
Average10L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

Divis Laboratories
Pharmaceuticals
Add Stock
Add Another

Mutual Funds Invested in Divis Laboratories

Fund name
AUM
PGIM India Healthcare Fund
10.34%
ICICI Prudential Nifty Pharma Index Fund
9.65%
Bajaj Finserv Healthcare Fund
9.21%

Divis Laboratories Returns Calculator

Ex-date: 24 Jul 2026

Divis Laboratories Latest News

1 day ago
NIFTY Pharma rallies nearly 3% to hit fresh new peak; Divi’s Labs, Gland Pharma lead gains after Q2 results
1 day ago
Divi's Laboratories shares hit 52-week high on robust Q2 earnings; analysts flag growth opportunities
1 day ago
NIFTY, SENSEX continue to trade lower in noon deals; HDFC Bank, SBI, L&T, PVR Inox, Divi's Labs among top buzzing stocks
2 days ago
Sun Pharma, Divi’s Lab, Wockhardt: Pharma stocks surge up to 8% during Muhurat Trading session; why did stocks rally today?
3 weeks ago
Apollo Hospitals, Max Health, Fortis: Healthcare stocks to post strong Q2 earnings; volumes, capacity additions in focus
1 month ago
Sun Pharma to Zydus: Healthcare stocks outperform broader market despite price pressure; can they sustain growth?
2 months ago
Lenskart, Sai Life Sciences, Redington among six NIFTY 500 stocks touching all-time high on Sept 8; check full list
2 months ago
Sun Pharma, Laurus Labs, Mankind Pharma, others drag Nifty Pharma down 1.6%; here’s what investors should know
2 months ago
NIFTY Pharma surges over 3% on India-US trade deal boost; Cipla, Sun Pharma, Dr Reddy's, others gain
3 months ago
Torrent Pharma, Mankind, Cipla, others lift Nifty Pharma 1.8%; why are pharma stocks rising in weak market?
Showing news item 1 of 10

Top Gainers

CHEMPLASTS Share Price
₹237.83
+24.42 (+11.44%)
DATAPATTNS Share Price
₹4025.00
+321 (+8.67%)
QUESS Share Price
₹345.70
+27.15 (+8.52%)
SPARC Share Price
₹210.80
+13.77 (+6.99%)
GLAXO Share Price
₹2710.00
+170.4 (+6.71%)
See more

Top Losers

RRKABEL Share Price
₹1969.40
-146 (-6.9%)
FINCABLES Share Price
₹1232.40
-76.6 (-5.85%)
ALIVUS Share Price
₹1474.40
-84.3 (-5.41%)
TTML Share Price
₹39.33
-2.18 (-5.25%)
STLTECH Share Price
₹670.95
-35.3 (-5%)
See more

Divis Laboratories Share Price FAQs

Please be aware that Divis Laboratories stock prices are subject to continuous fluctuations due to various factors.